×

Month: April 2021

A longer life does not have to me more time spent sick or frail if we develop the technology to address the causes of aging.
Whenever the topic of increasing human lifespan is discussed, the concern is sometimes raised that a longer life would mean a life spent frail and decrepit. This is sometimes known as the Tithonus error and shows a fundamental misunderstanding of the aims of rejuvenation biotechnology. The concern is based on the ancient Greek myth of...
Blood-brain barrier
Research suggests that the degradation of the blood-brain barrier over time is a factor in the development of brain diseases. An organ we don't want to age As our brains age, we experience memory loss, a decreased ability to multitask, a lower attention span, and slower information processing [1, 2]. Severe diseases can occur as...
STSTW Dog Aging Project 2
On this episode of Science to Save the World, Lifespan.io's general science show, we continue our discussion of how the Dog Aging Project aims to understand how genes, lifestyle, and environment influence aging so that dogs and their humans can live longer and healthier lives. Our nonprofit mission is to increase healthy human lifespan, for...
Scarring
Researchers have been trying to find out how to stop the formation of scars for decades, and now, thanks to a new mouse study, they are one step closer. Scars are a fast but poor repair Many of us have scars of one kind or another from accidents or surgery. As unpleasant as they are,...
Smell of Food
Experiments by researchers in China and the US have shown that the smell of food is enough to reduce the lifespan gains caused by dietary restriction in nematodes. By unraveling the genetic and neurological network behind this, the team found evidence that the same might hold true in mammals. Dietary restriction is more than a...
BioAge logo
BioAge Labs is off to a fast start in 2021, with two drugs in its pipeline now undergoing clinical trials and a third planned to start in the near future. BioAge Labs Building momentum After a $90 million Series C funding round closed late last year, BioAge has moved quickly to start the new year....